The Evolving Treatment Landscape of Adult Ph+ve ALL: The CLSG-ALL-2 Study
We invite you to join a discussion about the upcoming CLSG-ALL-2 Trial.
0 events found.
Latest Past Events
Management of FLT3-Mutated AML: What’s New in 2026?
We invite you to join a discussion about the management of FLT3-mutated AML and what’s new in 2026. The discussion will cover the impact of newly available Quizartinib on Canadian practice, and recent advances in FLT3-ITD MRD testing.
Controversies in the Management of AML in the Elderly 2025: An FAQ-Based Discussion
Series of webinars to discuss Acute Leukemia management dilemmas. The first one will be a discussion of ongoing questions in the administration of AML in the Elderly.